impact factor
logo
 

Letters to the Editor

 

Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment?


1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology Unit, Meyer Children’s University Hospital, Florence, and Neurofarba Department, University of Florence, Italy. ilamaccora@gmail.com
  2. Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy.
  3. Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy.
  4. Ophthalmology Unit, Meyer Children’s University Hospital, Florence, Italy.
  5. Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy.
  6. Rheumatology Unit, Meyer Children’s University Hospital, Florence, and Neurofarba Department, University of Florence, Italy.
  7. Rheumatology Unit, Meyer Children’s University Hospital, Florence, and Neurofarba Department, University of Florence, Italy.

CER14481
2021 Vol.39, N°6
PI 1453, PF 1454
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 34128787 [PubMed]

Received: 31/01/2021
Accepted : 12/04/2021
In Press: 08/06/2021
Published: 26/11/2021

Rheumatology Article